Insights from 2023 ESMO Asia Annual Meeting
Playback speed
10 seconds
ESMO Asia 2023 Insights: "AEs as Potential Predictive Factors of Activity in Patients With Advanced HCC Treated With Atezolizumab + Bevacizumab"
By
Insights from 2023 ESMO Asia Annual Meeting
FEATURING
Mara Persano
By
Insights from 2023 ESMO Asia Annual Meeting
FEATURING
Mara Persano
41 views
January 17, 2024
Comments 0
Login to view comments.
Click here to Login
Gastrointestinal